A gene on human chromosome 13, which instructs the cell to make a protein that normally helps to repair damaged DNA and suppress cell growth. A person who inherits certain mutations in a BRCA2 gene has a higher risk of getting breast cancer, ovarian cancer and certain other types of cancer.
Pioneering geneticists Professor Zosia Miedzybrodzka and Professor Meena Upadhyaya were both recognised in the King's 2026 New Year Honours list...
The first session of 'What Does Genomics Mean for Fertility Treatment?' – the 2025 Annual Conference of PET – explored the growing use of expanded carrier screening...
The fifth session of 'What Does Genomics Mean for Fertility Treatment?' – the 2025 Annual Conference of PET – brought together clinical, scientific and ethical perspectives on the relationship between genomics and donor conception...
A new algorithm-based surveillance test for ovarian cancer is being offered on the NHS to women carrying BRCA1 or BRCA2 mutations...
Health advocates in New Zealand are lobbying the Government to ban insurance companies from considering genetic test results when offering cover...
A new combination treatment has yielded 100 percent survival for patients with 'aggressive' breast cancers, three years post-surgery...
'Established in 2007, in a gale of publicity, 23andMe benefitted from the valetudinarian personal genetic healthcare imaginary that appeared in the wake of the Human Genome Project,' writes Dr Pete Mills, as he documents the rise and fall of 23andMe...
The British health insurance and healthcare company Bupa plans to offer an approach to people's genomic data that, it is claimed, can evaluate an individual's risk of developing seven common diseases...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
